VistaGen obtains exclusive global rights to 3 proprietary stem cell … – pharmabiz.com
|
VistaGen obtains exclusive global rights to 3 proprietary stem cell …
pharmabiz.com VistaGen Therapeutics, Inc. (VSTA), a clinical-stage biopharmaceutical company, has secured exclusive worldwide commercial rights to three patent-pending stem cell technologies from University Health Network (UHN), Canada's largest research hospital. |
